Radiogenesis Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Radiogenesis General Information

Description

Developer of a computational drug design platform intended for the creation of novel radiopharmaceuticals. The company's platform utilizes generative design, biological foundation models, and iterative wet lab validation, enabling oncology researchers to accelerate the development of targeted radioligand therapies for metastatic cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Amsterdam
  • Netherlands
+31 06
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Amsterdam
  • Netherlands
+31 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Radiogenesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jun-2026 Completed Startup
To view Radiogenesis’s complete valuation and funding history, request access »

Radiogenesis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arcas Ventures Venture Capital Minority
Golden Egg Check Capital Venture Capital Minority
TK & Partners Venture Capital Minority
To view Radiogenesis’s complete investors history, request access »

Radiogenesis FAQs

  • When was Radiogenesis founded?

    Radiogenesis was founded in 2025.

  • Where is Radiogenesis headquartered?

    Radiogenesis is headquartered in Amsterdam, Netherlands.

  • What industry is Radiogenesis in?

    Radiogenesis’s primary industry is Biotechnology.

  • Is Radiogenesis a private or public company?

    Radiogenesis is a Private company.

  • What is Radiogenesis’s current revenue?

    The current revenue for Radiogenesis is .

  • Who are Radiogenesis’s investors?

    Arcas Ventures, Golden Egg Check Capital, and TK & Partners have invested in Radiogenesis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process